Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
87.89
-0.78 (-0.88%)
At close: Jun 26, 2026, 4:00 PM EDT
88.00
+0.11 (0.13%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Spyre Therapeutics Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Spyre Therapeutics stock have an average target of 101.5, with a low estimate of 80 and a high estimate of 135. The average target predicts an increase of 15.49% from the current stock price of 87.89.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Spyre Therapeutics stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 17 | 17 | 17 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Buy Reiterates $115 → $135 | Buy | Reiterates | $115 → $135 | +53.60% | Jun 23, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $107 | Buy | Reiterates | $107 | +21.74% | Jun 22, 2026 |
| Wedbush | Wedbush | Buy Maintains $80 → $100 | Buy | Maintains | $80 → $100 | +13.78% | Jun 16, 2026 |
| Jefferies | Jefferies | Buy Maintains $95 → $98 | Buy | Maintains | $95 → $98 | +11.50% | Jun 16, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.95
from -1.98
EPS Next Year
-3.13
from -2.95
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.29 | -1.61 | |
| Avg | -2.95 | -3.13 | |
| Low | -3.82 | -4.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.